MDB Capital Holdings, LLC (NASDAQ:MDBH) Sees Large Growth in Short Interest

Posted by Stanley Muller on Jul 30th, 2026

MDB Capital Holdings, LLC (NASDAQ:MDBH – Get Free Report) was the recipient of a significant increase in short interest in July. As of July 15th, there was short interest totaling 3,170 shares, an increase of 93.4% from the June 30th total of 1,639 shares. Based on an average daily volume of 1,140 shares, the days-to-cover ratio is presently 2.8 days. Currently, 0.1% of the shares of the stock are sold short.

MDB Capital Stock Performance

Shares of NASDAQ:MDBH opened at $3.05 on Thursday. The company has a market cap of $31.41 million, a price-to-earnings ratio of -1.44 and a beta of 1.17. MDB Capital has a 12 month low of $2.45 and a 12 month high of $4.80. The company has a 50-day moving average price of $3.24 and a 200 day moving average price of $3.29.

MDB Capital (NASDAQ:MDBH – Get Free Report) last issued its quarterly earnings data on Thursday, May 14th. The company reported ($0.65) earnings per share for the quarter.

Hedge Funds Weigh In On MDB Capital

Several large investors have recently modified their holdings of MDBH. DRW Securities LLC purchased a new stake in MDB Capital during the 4th quarter valued at $40,000. Citadel Advisors LLC bought a new stake in MDB Capital in the third quarter worth $43,000. Finally, Raymond James Financial Inc. purchased a new position in MDB Capital during the second quarter worth $27,000. Institutional investors own 0.35% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of MDB Capital in a research note on Thursday, July 2nd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, MDB Capital presently has an average rating of “Sell”.

Get Our Latest Stock Report on MDBH

MDB Capital Company Profile

(Get Free Report)

MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business.